A Preliminary Feasibility Efficacy of Participation in Daily Life Promotion Program
National Taiwan University Hospital, Taiwan
1 other identifier
interventional
30
1 country
1
Brief Summary
Efficacy of Participation in Daily Life Promotion Program for Patients with Chronic Stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Jun 2016
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 3, 2016
CompletedFirst Posted
Study publicly available on registry
June 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJune 16, 2016
June 1, 2016
2.5 years
June 3, 2016
June 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stroke Impact Scale(SIS)
quality of life measure
one year
Secondary Outcomes (7)
Postural Assessment Scale for Stroke patients(PASS)
one year
Action Research Arm Test(ARAT)
one year
Fugl-Meyer Assessment(FMA)
one year
self-rated abilities for health practice scale
one year
WHO Quality of Life-BREF (Taiwan version)
one year
- +2 more secondary outcomes
Study Arms (2)
intervention group
EXPERIMENTALDaily Life Promotion Program
control group
EXPERIMENTALgeneral rehabilitation treatment
Interventions
Eligibility Criteria
You may qualify if:
- Patient with stroke after 6 months.
- Must be able to follow orders and no other cognition impairment, Mini Mental State Examination scale must \>20.
You may not qualify if:
- Clinical diagnosis of Dementia or Psychosis.
- Clinical diagnosis of Musculoskeletal disorders or Nervous system diseases.
- Patient with Congestive Heart Failure, Hypertension, Atrial fibrillation.
- Could not communication with others.
- Foreigner.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Test2, test3, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
I MING HSIAO
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2016
First Posted
June 16, 2016
Study Start
June 1, 2016
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
June 16, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will not share